Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Within-Subject Trial of Allogeneic Nerve Grafting After Bilateral Nipple-Sparing Mastectomy With Implant-Based Reconstruction

NCT07819357 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT07819357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Within-Subject Trial of Allogeneic Nerve Grafting After Bilateral Nipple-Sparing Mastectomy With Implant-Based Reconstruction
Lead sponsor
Endeavor Health
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
December 31, 2030
Enrollment
45 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast reconstruction following mastectomy